Mayo Clinic study indicates medication for ADHD may help student outcomesSeptember 19, 2007ROCHESTER, Minn. -- In an 18-year-study on attention-deficit hyperactivity disorder (ADHD), Mayo Clinic researchers found that treatment with prescription stimulants is associated with improved long-term academic success of children with ADHD. The Mayo Clinic results are the first population-based data to show stimulant drug therapy helps improve long-term school outcomes. A related Mayo Clinic study reveals that compared to children without AD/HD, children with ADHD are at risk for poor long-term school outcomes such as low achievement in reading, absenteeism, repeating a grade, and dropping out of school. Both studies appear in the current edition of the Journal of Development & Behavioral Pediatrics, (http://www.jrnldbp.com). Nearly 2 million children, or approximately 3 percent to 5 percent of young children in the United States, have ADHD. This disorder affects a child's ability to focus, concentrate and control impulsive behavior (http://www.nimh.nih.gov/publicat/adhd.cfm). This disorder is so common that most school classrooms have at least one child with clinically-diagnosed ADHD.
"In this study, treatment with stimulant medication during childhood was associated with more favorable long-term school outcomes," explains William Barbaresi, M.D., Mayo Clinic pediatrician and lead author of the reports. Significance of the Mayo Clinic Studies The two Mayo Clinic studies are the first population-based, long-term studies to investigate links between ADHD, school performance and factors that modify long-term school performance of children with ADHD. Researchers followed the children from the time they were born for, on average, 18 years. Of the more than 5,000 children evaluated, 370 (277 boys and 93 girls) were identified as having ADHD. Researchers matched them by age and gender to 740 children who did not meet the research criteria for having AD/HD. In addition to medical stimulants such as methylphenidate, also called Ritalin, the study examined the effects on school outcomes of maternal age, socioeconomic background, and special education services the students received. School Outcome Results At a Glance The children treated with stimulants typically began taking medication in elementary school and received it for nearly three years -- on average, for 30.4 months. Results indicate: * Gender: Girls and boys with untreated ADHD were equally vulnerable to poor school outcomes -- and girls may be at risk for being under-identified as having ADHD, and therefore undertreated. * Reading: By age 13, on average, stimulant dose was modestly correlated with improved reading achievement scores. * Absenteeism: Both treatment with stimulants and longer duration of medication were associated with decreased absenteeism. * Grade Retention: Children with A/HD who were treated with stimulants were 1.8 times less likely to be retained a grade than children with ADHD who were not treated. Implications for Parents and Caregivers Dr. Barbaresi believes that both studies provide the first solid evidence of the long-term negative academic performance associated with untreated ADHD -- as well as evidence for the best way to manage this problem. Dr. Barbaresi says, "The finding that treatment with stimulant medications is associated with long-term improvement in school outcomes is significant. Previously, there was evidence that treatment with stimulant medications improved short-term academic performance, but there was no good evidence that long-term outcomes are better with stimulant treatment. Our data can guide clinicians in their efforts to help children with ADHD succeed in school." About the Studies The Mayo Clinic team had a unique ability to identify groups of children with and without ADHD. Mayo Clinic has maintained a comprehensive communitywide medical records database since 1935, and researchers had access to all conditions, diagnoses and treatments the children received. In addition, Mayo obtained a research agreement with Independent School District #535, Rochester, Minn., including public and private schools, to access non-identifiable school records of all children born in Rochester between Jan. 1, 1976 and Dec. 31, 1982. This enabled researchers to correlate school performance of both children with and without ADHD in terms of medical conditions, maternal age, socioeconomic status and special education efforts. Mayo Clinic | |||||||||||||||||||||
|
Related ADHD Current Events and ADHD News Articles Learning to shape your brain activity A study in the Oct. 1 issue of the journal Sleep shows that the successful manipulation of sensorimotor rhythm (SMR) amplitude by instrumental SMR conditioning (ISC) improved sleep quality as well as declarative learning. ISC might thus be considered a promising non-pharmacological treatment for primary insomnia. Move over mean girls -- boys can be socially aggressive, too Society holds that when it comes to aggression, boys hit and punch, while girls spread rumors, gossip, and intentionally exclude others, a type of aggression that's called indirect, relational, or social. First generation antipsychotic drugs as effective as newer ones in some children Nearly every child who receives an antipsychotic medicine is first prescribed one of the second-generation, or "atypical" drugs, such as olanzapine and risperidone. However, there has never been evidence that these drugs are more effective than the older, first-generation medications. Premature children 4 times more likely to have behavioral disorders Children born prematurely are four times more likely to have emotional problems or behavioural disorders, according to research led by the University of Warwick. Study examines relationship between low birth weight and psychiatric problems in children Low-birth-weight children appear to be at higher risk for psychiatric disturbances from childhood through high school than normal-birth-weight children, according to a report in the September issue of Archives of General Psychiatry, one of the JAMA/Archives journals. Barrow scientists work their magic Two neuroscientists at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center are turning magic tricks into science. APA task force recommends dissemination of evidence-based practice An estimated 15 million American children are diagnosed with a mental disorder, but only about a quarter of them are getting appropriate treatment based on scientific evidence. Innovative program focuses on improved care for children with ADHD An innovative program is helping busy primary care physicians improve the care they provide for school-aged children with Attention-Deficit/Hyperactivity Disorder (ADHD), according to a study led by researchers at Cincinnati Children's Hospital Medical Center and published in the July edition of Pediatrics. Did the gene for ADHD help our nomadic ancestors? An ADHD-associated version of the human gene DRD4 is linked to better health among nomadic tribesmen, but may cause malnourishment in their settled cousins, according to new research by a team directed by an anthropologist at the University of Wisconsin-Milwaukee (UWM). PET imaging focuses on medication's purported ability to improve mental performance Concerned by the growing numbers of people using stimulant medications such as methylphenidate (MP)-either legally or illegally-to improve attention and focus, researchers used positron emission tomography (PET) imaging with the radiotracer fluorodeoxyglucose (FDG) to assess the effects of the drug on brain function in the normal human brain. More ADHD Current Events and ADHD News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||